Examples of using Dose reductions in English and their translations into Polish
{-}
-
Medicine
-
Colloquial
-
Official
-
Ecclesiastic
-
Ecclesiastic
-
Financial
-
Official/political
-
Programming
-
Computer
The starting dose of 175 mg was associated with a significant incidence of adverse events and required dose reductions/delays in the majority of patients.
Substantial dose reductions are generally required for homozygous-TPMT deficiency patients to avoid the development of life threatening bone marrow suppression.
If recurrence after irinotecan and 5-FU dose reductions, reduction of ZALTRAP dose to 2 mg/kg could be considered.
in combination with chemotherapy, standard dose reductions for the chemotherapeutic medicinal products should be applied.
in combination with chemotherapy, standard dose reductions for the chemotherapeutic medicinal products should be applied see section 4.8.
Dose reductions were noted to slow
Dose reductions of up to 90% were required in some patients at the end of week 2.
Dose reductions are recommended for severe or persistent neutropenia and thrombocytopenia as described in Table 1.
No dose reductions are recommended, but delay or discontinuation of TMZ administration should
Your doctor will decide whether treatment has to be stopped if skin reactions reappear after several dose reductions.
A maximum of two consecutive dose reductions for each medicinal product, as described in Table 1,
Dose reductions and dose interruptions occurred in 79% and 72%,
Dose reductions are recommended for events that,
If adverse reactions occur after dose reductions to 1 mg,
There were significant dose reductions and delays of capecitabine or oxaliplatin administration mainly
Other potent inhibitors of CYP3A4, such as itraconazole and HIV protease inhibitors, may be expected to have similar effects and similar dose reductions should therefore be applied.
ROS1-positive NSCLC(N=1722), dose reductions associated with transaminase elevations occurred in 76(4%) patients.
Consult the full prescribing information of the co-administered medicinal product for relevant details of their posology including any dose reductions, contraindications and safety information.